![Firm to continue pimavanserin PDP program but postpones trials in AD psychosis and schizophrenia. [© fred goldstein - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Oct28_2010_297555_OldManInWheelchairWithNurse_BiovailEndsAcadiaParkinsonCollab3519081126-218x150.jpg "Parkinson’s Disease Reversed by Farnesol in Mice")
K. John Morrow Jr., PhD
John Morrow, Jr., PhD (kjohnmorrowjr@insightbb.com), is president of Newport Biotechnology Consultants. He is also the co-editor of “Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, published by John Wiley and Sons.
